Robert Reger

机构：National Institutes of Health, National Heart Lung and Blood Institute

发表论文 120 篇 · 总被引 2806 次 · h-index 21

代表论文

• Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus (2024 · Journal for ImmunoTherapy of Cancer · 被引 14)
• Final results of a phase I trial of HERV-E TCR transduced T cells for the treatment of HLA-A*11 patients with metastatic clear cell renal cell carcinoma (mccRCC). (2024 · Journal of Clinical Oncology · 被引 10)
• SARS-CoV-2 Immune Complex–Mediated Neutrophil Activation (2025 · Open Forum Infectious Diseases · 被引 7)
• Phase I results of human endogenous retrovirus type-E (HERV-E) TCR transduced T-cells in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC). (2023 · Journal of Clinical Oncology · 被引 5)
• Social Determinants modulate NK cell activity via obesity, LDL, and DUSP1 signaling (2023 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 4)
• REMOVED: Interim Results of a Phase II Trial of Omidubicel, Ex-Vivo Expanded Umbilical Cord Blood Transplantation in Patients with Treatment-Refractory Severe Aplastic Anemia (2025 · Transplantation and Cellular Therapy · 被引 2)